SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-089889
Filing Date
2023-08-10
Accepted
2023-08-10 17:13:37
Documents
7
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2322148d1_6k.htm 6-K 10848
2 EXHIBIT 99.1 tm2322148d1_ex99-1.htm EX-99.1 332599
3 EXHIBIT 99.2 tm2322148d1_ex99-2.htm EX-99.2 237717
4 EXHIBIT 99.3 tm2322148d1_ex99-3.htm EX-99.3 11312
5 EXHIBIT 99.4 tm2322148d1_ex99-4.htm EX-99.4 11237
6 GRAPHIC tm2322148d1_ex99-1img01.jpg GRAPHIC 17291
7 GRAPHIC tm2322148d1_ex99-2img01.jpg GRAPHIC 17291
  Complete submission text file 0001104659-23-089889.txt   641899
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 231160647
SIC: 2836 Biological Products, (No Diagnostic Substances)